{"id":16051,"date":"2023-01-30T14:49:08","date_gmt":"2023-01-30T13:49:08","guid":{"rendered":"https:\/\/www.laborberlin.com\/news\/persistent-but-atypical-germinal-center-reaction-among-3rd-sars-cov-2-vaccination-after-rituximab-exposure\/"},"modified":"2024-07-17T09:46:53","modified_gmt":"2024-07-17T07:46:53","slug":"persistent-but-atypical-germinal-center-reaction-among-3rd-sars-cov-2-vaccination-after-rituximab-exposure","status":"publish","type":"news","link":"https:\/\/www.laborberlin.com\/en\/news\/persistent-but-atypical-germinal-center-reaction-among-3rd-sars-cov-2-vaccination-after-rituximab-exposure\/","title":{"rendered":"Persistent but atypical germinal center reaction among 3rd SARS-CoV-2 vaccination after rituximab exposure"},"content":{"rendered":"","protected":false},"featured_media":0,"template":"","class_list":["post-16051","news","type-news","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Persistent but atypical germinal center reaction among 3rd SARS-CoV-2 vaccination after rituximab exposure - Labor Berlin<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.laborberlin.com\/en\/news\/persistent-but-atypical-germinal-center-reaction-among-3rd-sars-cov-2-vaccination-after-rituximab-exposure\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Persistent but atypical germinal center reaction among 3rd SARS-CoV-2 vaccination after rituximab exposure - Labor Berlin\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.laborberlin.com\/en\/news\/persistent-but-atypical-germinal-center-reaction-among-3rd-sars-cov-2-vaccination-after-rituximab-exposure\/\" \/>\n<meta property=\"og:site_name\" content=\"Labor Berlin\" \/>\n<meta property=\"article:modified_time\" content=\"2024-07-17T07:46:53+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.laborberlin.com\/en\/news\/persistent-but-atypical-germinal-center-reaction-among-3rd-sars-cov-2-vaccination-after-rituximab-exposure\/\",\"url\":\"https:\/\/www.laborberlin.com\/en\/news\/persistent-but-atypical-germinal-center-reaction-among-3rd-sars-cov-2-vaccination-after-rituximab-exposure\/\",\"name\":\"Persistent but atypical germinal center reaction among 3rd SARS-CoV-2 vaccination after rituximab exposure - Labor Berlin\",\"isPartOf\":{\"@id\":\"https:\/\/www.laborberlin.com\/#website\"},\"datePublished\":\"2023-01-30T13:49:08+00:00\",\"dateModified\":\"2024-07-17T07:46:53+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.laborberlin.com\/en\/news\/persistent-but-atypical-germinal-center-reaction-among-3rd-sars-cov-2-vaccination-after-rituximab-exposure\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.laborberlin.com\/en\/news\/persistent-but-atypical-germinal-center-reaction-among-3rd-sars-cov-2-vaccination-after-rituximab-exposure\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.laborberlin.com\/en\/news\/persistent-but-atypical-germinal-center-reaction-among-3rd-sars-cov-2-vaccination-after-rituximab-exposure\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.laborberlin.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Persistent but atypical germinal center reaction among 3rd SARS-CoV-2 vaccination after rituximab exposure\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.laborberlin.com\/#website\",\"url\":\"https:\/\/www.laborberlin.com\/\",\"name\":\"Labor Berlin\",\"description\":\"Competence of Charit\u00e9 and Vivantes.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.laborberlin.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Persistent but atypical germinal center reaction among 3rd SARS-CoV-2 vaccination after rituximab exposure - Labor Berlin","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.laborberlin.com\/en\/news\/persistent-but-atypical-germinal-center-reaction-among-3rd-sars-cov-2-vaccination-after-rituximab-exposure\/","og_locale":"en_US","og_type":"article","og_title":"Persistent but atypical germinal center reaction among 3rd SARS-CoV-2 vaccination after rituximab exposure - Labor Berlin","og_url":"https:\/\/www.laborberlin.com\/en\/news\/persistent-but-atypical-germinal-center-reaction-among-3rd-sars-cov-2-vaccination-after-rituximab-exposure\/","og_site_name":"Labor Berlin","article_modified_time":"2024-07-17T07:46:53+00:00","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.laborberlin.com\/en\/news\/persistent-but-atypical-germinal-center-reaction-among-3rd-sars-cov-2-vaccination-after-rituximab-exposure\/","url":"https:\/\/www.laborberlin.com\/en\/news\/persistent-but-atypical-germinal-center-reaction-among-3rd-sars-cov-2-vaccination-after-rituximab-exposure\/","name":"Persistent but atypical germinal center reaction among 3rd SARS-CoV-2 vaccination after rituximab exposure - Labor Berlin","isPartOf":{"@id":"https:\/\/www.laborberlin.com\/#website"},"datePublished":"2023-01-30T13:49:08+00:00","dateModified":"2024-07-17T07:46:53+00:00","breadcrumb":{"@id":"https:\/\/www.laborberlin.com\/en\/news\/persistent-but-atypical-germinal-center-reaction-among-3rd-sars-cov-2-vaccination-after-rituximab-exposure\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.laborberlin.com\/en\/news\/persistent-but-atypical-germinal-center-reaction-among-3rd-sars-cov-2-vaccination-after-rituximab-exposure\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.laborberlin.com\/en\/news\/persistent-but-atypical-germinal-center-reaction-among-3rd-sars-cov-2-vaccination-after-rituximab-exposure\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.laborberlin.com\/en\/"},{"@type":"ListItem","position":2,"name":"Persistent but atypical germinal center reaction among 3rd SARS-CoV-2 vaccination after rituximab exposure"}]},{"@type":"WebSite","@id":"https:\/\/www.laborberlin.com\/#website","url":"https:\/\/www.laborberlin.com\/","name":"Labor Berlin","description":"Competence of Charit\u00e9 and Vivantes.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.laborberlin.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/www.laborberlin.com\/en\/wp-json\/wp\/v2\/news\/16051","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.laborberlin.com\/en\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/www.laborberlin.com\/en\/wp-json\/wp\/v2\/types\/news"}],"wp:attachment":[{"href":"https:\/\/www.laborberlin.com\/en\/wp-json\/wp\/v2\/media?parent=16051"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}